Concepedia

Kevin Garofalo

KG

4

Publications

544

Citations

4

H-Index

2009

Active since

Affiliations

Momenta Pharmaceuticals (United States)(Current)

Harvard University

University Hospital of Zurich

Kevin Garofalo is an author at Momenta Pharmaceuticals (United States) specializing in medicine, pharmacology, and molecular medicine.

ORCID

Top concepts

Publications per year

2009–2015

4

Publications

4

Controlled tetra-Fc sialylation of IVIg results in a drug candidate with consistent enhanced anti-inflammatory activity

Nathaniel Washburn, Inessa Schwab, Daniel Ortiz et al. · Proceedings of the National Academy of Sciences · 2015 · 223 citations · Full text

, , +21

Oral l-serine supplementation reduces production of neurotoxic deoxysphingolipids in mice and humans with hereditary sensory autonomic neuropathy type 1

Kevin Garofalo, Anke Penno, Brian P. Schmidt et al. · Journal of Clinical Investigation · 2011 · 210 citations

, , +32

Overexpression of the Wild-Type SPT1 Subunit Lowers Desoxysphingolipid Levels and Rescues the Phenotype of HSAN1

Florian Eichler, Thorsten Hornemann, Alex McCampbell et al. · Journal of Neuroscience · 2009 · 98 citations · Full text

Equivalent Gene Expression Profiles between Glatopa™ and Copaxone®

Josephine D’Alessandro, Jay Duffner, Joël Pradines et al. · PLoS ONE · 2015 · 13 citations · Full text

, , +20

Rows per page

1–4 of 4